Additionally, α2,3-sialyltransferases, such as ST3Gal-III and ST3Gal-IV, are often upregulated in the course of gastric cancer and PDAC progression leading to a more invasive and metastatic phenotypes of the cancer cells (65–69). The gene discussed is ST3GAL4; the disease is gastric cancer.